Palvella Therapeutics (PVLA) Times Interest Earned (2014 - 2024)

Palvella Therapeutics (PVLA) has reported Times Interest Earned for 14 consecutive years, with -$0.05 the latest figure, recorded in Q1 2026.

• In Q1 2026, Times Interest Earned rose 76.82% year-over-year to -$0.05; the TTM figure through Mar 2026 stood at -$0.15 (up 72.29% YoY), while the FY2025 annual figure was -$0.29, down 94.76% from the prior year.
• Times Interest Earned rose to -$0.05 in Q1 2026 per PVLA's latest filing, from -$0.2 in the prior quarter.
• Across five years, Times Interest Earned topped out at $4.13 in Q2 2023 and bottomed at -$100.28 in Q2 2024.
• Historically, Times Interest Earned has averaged -$21.4 across 5 years, with a median of -$20.55 in 2022.
• Annual changes were most pronounced in 2023 — Times Interest Earned surged 120.08% — and 2024, when it slumped 2530.34%.
• Palvella Therapeutics' Times Interest Earned stood at -$14.4 in 2022, then surged by 41.9% to -$8.37 in 2023, then slumped by 188.32% to -$24.12 in 2024, then soared by 99.15% to -$0.2 in 2025, then surged by 76.82% to -$0.05 in 2026.
• Business Quant data shows PVLA's Times Interest Earned at -$0.05 in Q1 2026, -$0.2 in Q1 2025, and -$24.12 in Q4 2024.